Phase II trial of afamelanotide for vitiligo in Singapore.

Trial Profile

Phase II trial of afamelanotide for vitiligo in Singapore.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 03 Dec 2015

At a glance

  • Drugs Afamelanotide (Primary)
  • Indications Vitiligo
  • Focus Registrational; Therapeutic Use
  • Sponsors Clinuvel Pharmaceuticals
  • Most Recent Events

    • 03 Dec 2015 Preliminary results published in the Clinuvel Pharmaceuticals' media release.
    • 06 May 2014 Status changed from not yet recruiting to recruiting, as reported by a Clinuvel Pharmaceuticals media release.
    • 12 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top